Phenylketonuria is best treated when given as early as possible

Mar 29 - 2022

Phenylketonuria is best treated when given as early as possible

In phenylketonuria, the patient has a defective enzyme in the l-phenylalanine pathway, pku guidelines which prevents the normal conversion of l-phenylalanine to tyrosine and causes a large accumulation of tyrosine in the body.

Phenylketonuria can be screened for during pregnancy and is included as one of the mandatory prenatal tests during pregnancy.

Phenylalanine is used in the body to synthesize proteins and as a substance for thyroid hormones and adrenaline. Many patients with phenylketonuria have growth retardation if they are not treated in time.

In general, people with phenylketonuria have lower-than-normal IQs and can be significantly different from normal infants at four to nine months of age.

The difference between the IQ and the IQ of a normal infant can be significant at four to nine months of age. Most people with phenylketonuria have very dry skin and are prone to eczema, which can easily lead to scratches if the skin is slightly scratched.

People with phenylketonuria have an inhibition of the enzyme tyrosinase, which causes the breakdown of melanin synthesis in the body and in many cases causes their hair to turn light brown.

Phenylketonuria is a congenital disorder that is difficult to treat in most people, and people with phenylketonuria do not show any abnormalities in the early stages.

The disease is often misdiagnosed and must be treated as early as possible, and the younger the age of treatment, the better the outcome.